Unique asset acquisition ensures power supply for plant-based pharmaceutical manufacturing.
SASKATOON, MONDAY, AUGUST 25, 2014 – Prairie Plant Systems Inc. (PPS) announced today it has completed its purchase of Traxys Power Group Inc. (TPG), which will be renamed P.M. Power Group Inc., owner of the following assets in White Pine, Michigan:
"With Michigan’s energy policy (Public Act 295 of 2008) set to expire in 2015 just as new regulations from the United Stated Environmental Protection Agency (USEPA) will be requiring states to cut carbon pollution from existing power plants, we wanted to ensure that the highly specialized work we do in creating plant-based pharmaceuticals would not be in jeopardy as a result of power outages," said Brent Zettl, President and CEO of Prairie Plant Systems. "This strategic acquisition to maintain our own supply of consistent power will ensure that there will be no delay in the development of the drugs in our pipeline."
This unique asset acquisition by Prairie Plant Systems will position this Biotech company as the first to wholly control their own source of energy, primarily to be used in the growth chambers for the U.S. subsidiary, SubTerra LLC, located in White Pine, Michigan. Using biosecure underground growth chambers to cultivate and process biopharmaceutical plant species allows for the efficient use of research and development funds by reducing the costs associated with regulatory approvals for genetic containment in the early stages of biopharmaceutical development.
In addition, the SubTerra advantage includes the highest level of quality control (GMP, GAP, GLP), Level 2 containment meaning there is no risk of unintended generic release, accelerated growth and improved crop production.
Steve Walsh, President of TPG Power Holdings LLC, the former owner of TPG, said "The Traxys Group has been at the White Pine site for over 10 years and recently completed the conversion of the White Pine Power Station from coal fired to natural gas fired which makes it a cleaner, more economical power station. This permanent conversion was done in accordance with EPA guidelines. As Traxys looks to focus its time and resources on its core business of metals and minerals trading, divestiture of the power group was seen as a logical strategic move."
About Prairie Plant Systems
Prairie Plant Systems is a biotechnology company with Canadian and U.S. facilities dedicated to the principle of manufacturing pharmaceuticals derived from harvested plants grown in biosecure Good Manufacturing Practice (GMP) production facilities. The core business activity includes growing and processing of medically valuable whole plant components for controlled substances, biosecure production of transgenic plants for development of unique genetic lines for commercialization and genetic transformation for tissue specific expression of pharmaceutical biologicals, requiring possible eukaryotic post-translation modification.
Prairie Plant Systems has a rich 20+year history in research, development, project management and commercialization of products.
Traxys is a leading physical commodity trader and merchant in the metals and natural resources sectors. Its logistics, marketing, distribution, supply chain management and trading activities are conducted by over 300 employees, in over 20 offices worldwide, and its annual turnover is in excess of $6 billion. Traxys is headquartered in Luxembourg.
For more information:
President & CEO
Prairie Plant Systems
TPG Power Holdings LLC
Dara Willis Communications